ea0070aep1097 | Hot topics (including COVID-19) | ECE2020
Marlier Joke
, Bruno Lapauw
, T’sjoen Guy
, Defreyne Justine
Introduction: Thyroid hormone (TH) replacement therapy in patients with central hypothyroidism (CHT) cannot be reliably guided by TSH levels. Guidelines suggest substitution doses between 1.2–1.6 µg/kg body weight, aiming for free thyroxine levels (fT4) prior to intake in the upper part of normal. However, variability in TH metabolism, concomitant treatments and inaccurate interpretation of TSH levels still puts patients with CHT at risk for inappropriate substituti...